Address : 1 Broadway, Cambridge, Massachusetts 02142, United States
Phone Number : +1 617-861-2946
Industries : Research
Website : neurosense-tx.com
Advancing research, development and therapy for ALS and additional CNS indications.NeuroSense Therapeutics Ltd. (NASDAQ: NRSN) is a clinical stage Biotech company focusing on the development of a ground-breaking treatment for ALS patients, as well as other neurodegenerative diseases.Currently in conducting a Phase 2b, double-blind, randomized, placebo controlled clinical study in ALS patients globally.
Employees Total : 30
Total Funding : 13.1M
Latest Funding : 12M
Public Company : Yes
Trade Symbol : NRSN
Trade Exchange : Nasdaq
Market Cap :
Founded in : 2016
Twitter : NeurosenseT
Facebook : neurosensetx
Linkedin : neurosense-therapeutics
Instagram : neurosensetx
Email Providers : Gmail
Tech : Google Apps
Analytics and Tracking : Google Analytics
Tag Management : Google Tag Manager
Load Balancers : Nginx
Fonts : Google Font API
Last Updated : 2023-12-07
Clinica Independencia Santo Domingo, Distrito Nacional, Dominican Republic |
Lifemark Auckland, New Zealand Civic & Social Organization |
Watkins Insurance Group Austin, Texas, United States Insurance |
SSE Brasil - Sirio Solutions Engineering Santos, State of São Paulo, Brazil Machinery |
Capital Benefits Group Brentwood, Tennessee, United States Insurance |
Guy Hurley, LLC Rochester Hills, Michigan, United States Insurance |